Calithera Biosciences, Inc.
Ectonucleotidase inhibitors and methods of use thereof

Last updated:

Abstract:

The invention relates to novel heterocyclic compounds having CD73 inhibitory activity and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.

Status:
Grant
Type:

Utility

Filling date:

27 Sep 2019

Issue date:

16 Nov 2021